Financhill
Buy
61

WAT Quote, Financials, Valuation and Earnings

Last price:
$350.95
Seasonality move :
5.54%
Day range:
$344.11 - $358.37
52-week range:
$279.24 - $423.56
Dividend yield:
0%
P/E ratio:
31.35x
P/S ratio:
6.90x
P/B ratio:
10.48x
Volume:
739.1K
Avg. volume:
604.8K
1-year change:
8.36%
Market cap:
$20.6B
Revenue:
$3B
EPS (TTM):
$11.02

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
WAT
Waters
$655.6M $2.22 5.28% 22.37% $387.19
DCTH
Delcath Systems
$19.2M $0.02 436.11% -93.78% $23.00
DGX
Quest Diagnostics
$2.6B $2.15 13.64% 26.94% $183.92
DHR
Danaher
$5.6B $1.64 1.51% 36.22% $247.17
LH
Labcorp Holdings
$3.4B $3.73 8.06% 71.93% $272.40
MTD
Mettler-Toledo International
$875.8M $7.88 1.08% -7.94% $1,260.38
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
WAT
Waters
$345.46 $387.19 $20.6B 31.35x $0.00 0% 6.90x
DCTH
Delcath Systems
$14.36 $23.00 $479.5M -- $0.00 0% 11.35x
DGX
Quest Diagnostics
$175.90 $183.92 $19.6B 22.24x $0.80 1.73% 1.97x
DHR
Danaher
$194.82 $247.17 $139.4B 37.83x $0.32 0.58% 5.97x
LH
Labcorp Holdings
$248.76 $272.40 $20.8B 28.76x $0.72 1.16% 1.59x
MTD
Mettler-Toledo International
$1,101.63 $1,260.38 $22.9B 27.47x $0.00 0% 6.09x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
WAT
Waters
42.61% 1.569 6.64% 1.14x
DCTH
Delcath Systems
-- 2.997 -- 10.46x
DGX
Quest Diagnostics
45.82% 0.589 30.74% 1.10x
DHR
Danaher
24.47% 0.491 11.23% 0.83x
LH
Labcorp Holdings
40.13% 0.886 28.53% 1.28x
MTD
Mettler-Toledo International
109.62% 1.436 8.45% 0.61x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
WAT
Waters
$385M $151.7M 19.29% 40.75% 23.75% $233.8M
DCTH
Delcath Systems
$13M $3M -97.08% -117.89% 68.93% -$1.2M
DGX
Quest Diagnostics
$863M $346M 7.26% 13.14% 13.12% $197M
DHR
Danaher
$3.5B $1.3B 5.53% 7.38% 20.92% $1.1B
LH
Labcorp Holdings
$948M $332.4M 5.27% 9.01% 9.9% -$107.5M
MTD
Mettler-Toledo International
$525.9M $219.5M 44.53% -- 24.74% $177.2M

Waters vs. Competitors

  • Which has Higher Returns WAT or DCTH?

    Delcath Systems has a net margin of 18.34% compared to Waters's net margin of -22.5%. Waters's return on equity of 40.75% beat Delcath Systems's return on equity of -117.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    58.18% $2.03 $3.4B
    DCTH
    Delcath Systems
    85.92% -$0.11 $68.7M
  • What do Analysts Say About WAT or DCTH?

    Waters has a consensus price target of $387.19, signalling upside risk potential of 12.08%. On the other hand Delcath Systems has an analysts' consensus of $23.00 which suggests that it could grow by 60.22%. Given that Delcath Systems has higher upside potential than Waters, analysts believe Delcath Systems is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    6 15 0
    DCTH
    Delcath Systems
    4 0 0
  • Is WAT or DCTH More Risky?

    Waters has a beta of 1.138, which suggesting that the stock is 13.849% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.722, suggesting its less volatile than the S&P 500 by 27.805%.

  • Which is a Better Dividend Stock WAT or DCTH?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or DCTH?

    Waters quarterly revenues are $661.7M, which are larger than Delcath Systems quarterly revenues of $15.1M. Waters's net income of $121.4M is higher than Delcath Systems's net income of -$3.4M. Notably, Waters's price-to-earnings ratio is 31.35x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 6.90x versus 11.35x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    6.90x 31.35x $661.7M $121.4M
    DCTH
    Delcath Systems
    11.35x -- $15.1M -$3.4M
  • Which has Higher Returns WAT or DGX?

    Quest Diagnostics has a net margin of 18.34% compared to Waters's net margin of 8.3%. Waters's return on equity of 40.75% beat Quest Diagnostics's return on equity of 13.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    58.18% $2.03 $3.4B
    DGX
    Quest Diagnostics
    32.54% $1.94 $12.9B
  • What do Analysts Say About WAT or DGX?

    Waters has a consensus price target of $387.19, signalling upside risk potential of 12.08%. On the other hand Quest Diagnostics has an analysts' consensus of $183.92 which suggests that it could grow by 4.56%. Given that Waters has higher upside potential than Quest Diagnostics, analysts believe Waters is more attractive than Quest Diagnostics.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    6 15 0
    DGX
    Quest Diagnostics
    8 10 0
  • Is WAT or DGX More Risky?

    Waters has a beta of 1.138, which suggesting that the stock is 13.849% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.524, suggesting its less volatile than the S&P 500 by 47.572%.

  • Which is a Better Dividend Stock WAT or DGX?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.73% to investors and pays a quarterly dividend of $0.80 per share. Waters pays -- of its earnings as a dividend. Quest Diagnostics pays out 38% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios WAT or DGX?

    Waters quarterly revenues are $661.7M, which are smaller than Quest Diagnostics quarterly revenues of $2.7B. Waters's net income of $121.4M is lower than Quest Diagnostics's net income of $220M. Notably, Waters's price-to-earnings ratio is 31.35x while Quest Diagnostics's PE ratio is 22.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 6.90x versus 1.97x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    6.90x 31.35x $661.7M $121.4M
    DGX
    Quest Diagnostics
    1.97x 22.24x $2.7B $220M
  • Which has Higher Returns WAT or DHR?

    Danaher has a net margin of 18.34% compared to Waters's net margin of 16.62%. Waters's return on equity of 40.75% beat Danaher's return on equity of 7.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    58.18% $2.03 $3.4B
    DHR
    Danaher
    61.16% $1.32 $67.3B
  • What do Analysts Say About WAT or DHR?

    Waters has a consensus price target of $387.19, signalling upside risk potential of 12.08%. On the other hand Danaher has an analysts' consensus of $247.17 which suggests that it could grow by 26.87%. Given that Danaher has higher upside potential than Waters, analysts believe Danaher is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    6 15 0
    DHR
    Danaher
    19 3 0
  • Is WAT or DHR More Risky?

    Waters has a beta of 1.138, which suggesting that the stock is 13.849% more volatile than S&P 500. In comparison Danaher has a beta of 0.804, suggesting its less volatile than the S&P 500 by 19.561%.

  • Which is a Better Dividend Stock WAT or DHR?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Danaher offers a yield of 0.58% to investors and pays a quarterly dividend of $0.32 per share. Waters pays -- of its earnings as a dividend. Danaher pays out 19.7% of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios WAT or DHR?

    Waters quarterly revenues are $661.7M, which are smaller than Danaher quarterly revenues of $5.7B. Waters's net income of $121.4M is lower than Danaher's net income of $954M. Notably, Waters's price-to-earnings ratio is 31.35x while Danaher's PE ratio is 37.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 6.90x versus 5.97x for Danaher. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    6.90x 31.35x $661.7M $121.4M
    DHR
    Danaher
    5.97x 37.83x $5.7B $954M
  • Which has Higher Returns WAT or LH?

    Labcorp Holdings has a net margin of 18.34% compared to Waters's net margin of 6.36%. Waters's return on equity of 40.75% beat Labcorp Holdings's return on equity of 9.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    58.18% $2.03 $3.4B
    LH
    Labcorp Holdings
    28.34% $2.52 $13.9B
  • What do Analysts Say About WAT or LH?

    Waters has a consensus price target of $387.19, signalling upside risk potential of 12.08%. On the other hand Labcorp Holdings has an analysts' consensus of $272.40 which suggests that it could grow by 9.5%. Given that Waters has higher upside potential than Labcorp Holdings, analysts believe Waters is more attractive than Labcorp Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    6 15 0
    LH
    Labcorp Holdings
    13 4 0
  • Is WAT or LH More Risky?

    Waters has a beta of 1.138, which suggesting that the stock is 13.849% more volatile than S&P 500. In comparison Labcorp Holdings has a beta of 0.826, suggesting its less volatile than the S&P 500 by 17.43%.

  • Which is a Better Dividend Stock WAT or LH?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Labcorp Holdings offers a yield of 1.16% to investors and pays a quarterly dividend of $0.72 per share. Waters pays -- of its earnings as a dividend. Labcorp Holdings pays out 32.59% of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios WAT or LH?

    Waters quarterly revenues are $661.7M, which are smaller than Labcorp Holdings quarterly revenues of $3.3B. Waters's net income of $121.4M is lower than Labcorp Holdings's net income of $212.8M. Notably, Waters's price-to-earnings ratio is 31.35x while Labcorp Holdings's PE ratio is 28.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 6.90x versus 1.59x for Labcorp Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    6.90x 31.35x $661.7M $121.4M
    LH
    Labcorp Holdings
    1.59x 28.76x $3.3B $212.8M
  • Which has Higher Returns WAT or MTD?

    Mettler-Toledo International has a net margin of 18.34% compared to Waters's net margin of 18.51%. Waters's return on equity of 40.75% beat Mettler-Toledo International's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    58.18% $2.03 $3.4B
    MTD
    Mettler-Toledo International
    59.51% $7.81 $1.9B
  • What do Analysts Say About WAT or MTD?

    Waters has a consensus price target of $387.19, signalling upside risk potential of 12.08%. On the other hand Mettler-Toledo International has an analysts' consensus of $1,260.38 which suggests that it could grow by 14.41%. Given that Mettler-Toledo International has higher upside potential than Waters, analysts believe Mettler-Toledo International is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    6 15 0
    MTD
    Mettler-Toledo International
    3 11 0
  • Is WAT or MTD More Risky?

    Waters has a beta of 1.138, which suggesting that the stock is 13.849% more volatile than S&P 500. In comparison Mettler-Toledo International has a beta of 1.396, suggesting its more volatile than the S&P 500 by 39.573%.

  • Which is a Better Dividend Stock WAT or MTD?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mettler-Toledo International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Mettler-Toledo International pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or MTD?

    Waters quarterly revenues are $661.7M, which are smaller than Mettler-Toledo International quarterly revenues of $883.7M. Waters's net income of $121.4M is lower than Mettler-Toledo International's net income of $163.6M. Notably, Waters's price-to-earnings ratio is 31.35x while Mettler-Toledo International's PE ratio is 27.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 6.90x versus 6.09x for Mettler-Toledo International. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    6.90x 31.35x $661.7M $121.4M
    MTD
    Mettler-Toledo International
    6.09x 27.47x $883.7M $163.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 41.65% over the past day.

Buy
62
RGC alert for May 9

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
85
TPB alert for May 9

Turning Point Brands [TPB] is down 6.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock